Residential proximity to toxic metal-emitting industrial sites and toenail metal concentrations in a United States-wide prospective cohort
Daniel M, Ish J, Madrigal J, Chang C, Lawrence K, Fisher J, Levine K, Trottier B, Jones R, Sandler D, White A. Residential proximity to toxic metal-emitting industrial sites and toenail metal concentrations in a United States-wide prospective cohort. Environmental Research 2024, 258: 119466. PMID: 38908662, PMCID: PMC11323170, DOI: 10.1016/j.envres.2024.119466.Peer-Reviewed Original ResearchArea Deprivation IndexBlack womenToenail metal concentrationsAssociated with adverse health outcomesLow exposure prevalenceNon-Hispanic blacksNon-Hispanic whitesAdverse health outcomesMetal concentrationsMultivariate linear regressionNeighborhood deprivationBaseline residenceDeprivation indexSister StudyHealth outcomesExposure prevalenceDisadvantaged areasResidential proximityBlack participantsWhite participantsUnited StatesProspective cohortExposure to toxic metalsToenail concentrationsParticipantsFine Particulate Matter, Noise Pollution, and Greenspace and Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cohort.
Thomas A, Rhee J, Fisher J, Horner M, Jones R. Fine Particulate Matter, Noise Pollution, and Greenspace and Prostate Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cohort. Cancer Epidemiology Biomarkers & Prevention 2024, 33: 857-860. PMID: 38497801, PMCID: PMC11147690, DOI: 10.1158/1055-9965.epi-23-1413.Peer-Reviewed Original ResearchProstate cancer riskAssociated with prostate cancer riskCancer riskNoise exposureMale participantsArea Deprivation IndexFamily history of prostate cancerFine particulate matterTrial cohortEnrollment addressHistory of prostate cancerDeprivation indexPotential risk factorsGreenspace exposureEstimate associationsMultipollutant modelsCox regression modelsFamily historyProstate cancerSingle-pollutantCases of prostate cancerProspective ProstateRisk factorsU.S. studiesIncident prostate cancer risk